Taxoprexin® Treatment for Advanced Eye Melanoma

Clinical trial NCT00244816 · COMPLETED

Trial details

NCT number: NCT00244816
Sponsor: American Regent, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2005-10-01
Primary completion: 2008-06-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.